Award
National Institute of Neurological Disorders and Stroke 5R01NS122163-05
Immuno-Cell Therapy for Brain Tumors
Recipient
Massachusetts General Hospital
Award Amount
$597,585.00
Ceiling
$597,585.00
Awarded
December 19, 2025
Identifier
5R01NS122163-05
The award supports research on using olfactory ensheathing cells to treat glioblastoma by targeting glioma stem cells, enhancing susceptibility to conventional therapies, and activating anti-tumor immunity.
Description
This project aims to evaluate olfactory ensheathing cells as a novel therapy for glioblastoma, focusing on their ability to target tumor stem cells, modulate immune response, and deliver therapeutic agents.